-transparent.png){kind=logo}
BOW is a 'new' low-frequency red-cell antigen, detected in 2 unrelated English blood donors, that is sensitive to alpha-chymotrypsin and pronase. Anti-BOW is present in many polyspecific reagents used to define low-frequency antigens. Red-cell groups of the proposita, R.B., and her family show that the BOW blood group segregates independently from the ABO, Rh, MNSs, P1 and Kell blood group systems.
Related Publications
M A Chaves, and
M R Leak, and
J Poole, and
C M Giles
January 1984,
Vox sanguinis,
M A Chaves, and
M R Leak, and
J Poole, and
C M Giles
January 1983,
Vox sanguinis,
M A Chaves, and
M R Leak, and
J Poole, and
C M Giles
June 1980,
Vox sanguinis,
M A Chaves, and
M R Leak, and
J Poole, and
C M Giles
January 1986,
Vox sanguinis,
M A Chaves, and
M R Leak, and
J Poole, and
C M Giles
January 1994,
Vox sanguinis,
M A Chaves, and
M R Leak, and
J Poole, and
C M Giles
January 1983,
Vox sanguinis,
M A Chaves, and
M R Leak, and
J Poole, and
C M Giles
January 1988,
Vox sanguinis,
M A Chaves, and
M R Leak, and
J Poole, and
C M Giles
February 1981,
Revue francaise de transfusion et immuno-hematologie,
M A Chaves, and
M R Leak, and
J Poole, and
C M Giles
January 1982,
Transfusion,
M A Chaves, and
M R Leak, and
J Poole, and
C M Giles
January 1982,
Human heredity,
